| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
|
|
|
|||||||
|
|||||||||
Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol 54, Issue 2 M65-M69, Copyright © 1999 by The Gerontological Society of America
JOURNAL ARTICLE |
AB Mitnitski, JE Graham, AJ Mogilner and K Rockwood
Division of Geriatric Medicine, Dalhousie University, Halifax, Nova Scotia.
BACKGROUND: Functional impairment over time is a necessary condition for the diagnosis of dementia. Increasingly, it is recognized that rates of decline may not follow a linear progression. This variability may indicate that dementia in Alzheimer's disease represents disease rather than inevitable aging. In order to investigate decline in function in dementia, we developed a model of the rate of decline in functions in Alzheimer's disease and in other dementias in comparison with normal aging. METHODS: Secondary analysis of a cross-sectional, representative sample of Canadians aged 65 and older (N = 2,914) was performed. We calculated a measure identified as an impairment index, defined as the probability of the occurrences of an impairment or disability in a structured clinical examination. RESULTS: The rate of functional decline varies for different diagnostic groups and increases with severity of the disease. The distribution for the rate of decline in dementia is distinct from that in aging without cognitive impairment. In those without cognitive impairment, the distribution is exponential. Elderly persons with dementia of any type showed a log- normal distribution. CONCLUSIONS: The difference in the distributions between aging with and without dementia likely reflects fundamental differences in the processes of decline in functions in the two groups. This suggests that the declines seen in persons with dementia are distinct from normal aging. It also has implications for the testing of antidementia medications, in that modeling treatment effects based on an assumption of linear decline is likely to be flawed.
This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)
|
|
 |
|
  K Rockwood Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Broe, J.R. Hodges, E. Schofield, C.E. Shepherd, J.J. Kril, and G.M. Halliday Staging disease severity in pathologically confirmed cases of frontotemporal dementia Neurology, March 25, 2003; 60(6): 1005 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Rockwood, J E Graham, and S Fay Goal setting and attainment in Alzheimer's disease patients treated with donepezil J. Neurol. Neurosurg. Psychiatry, November 1, 2002; 73(5): 500 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Sands, K. Yaffe, L.-Y. Lui, A. Stewart, C. Eng, and K. Covinsky The Effects of Acute Illness on ADL Decline Over 1 Year in Frail Older Adults With and Without Cognitive Impairment J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): M449 - 454. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Sehl and F. E. Yates Kinetics of Human Aging: I. Rates of Senescence Between Ages 30 and 70 Years in Healthy People J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2001; 56(5): 198B - 208. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| All GSA journals | The Gerontologist |
| Journals of Gerontology Series B: Psychological Sciences and Social Sciences | |
